Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 27 2015

Print RSS Feed

Trials & Filings in Brief: Nov. 18, 2013

By Gil Roth

Published November 18, 2013
Phase II
ChanRx posts positive A-Fib data . . . read more

Phase III
AbbVie, Enanta show HCV results . . . read more

Gilead gets EC approval for Vitekta . . . read more

Merck's Noxafil IV gets priority review . . . read more

Sanofi ends JAK2 development . . . read more

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On